Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

N. Galie; J.A. Barbera; A.E. Frost; H.A. Ghofrani; M.M. Hoeper; V.V. McLaughlin; A.J. Peacock; G. Simonneau; J.L. Vachiery; E. Grunig; R.J. Oudiz; A. Vonk-Noordegraaf; R.J. White; C. Blair; H. Gillies; K.L. Miller; J.H.N. Harris; J. Langley; L.J. Rubin

doi:10.1056/NEJMoa1413687

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

N. Galie
, J.A. Barbera
, A.E. Frost
, H.A. Ghofrani
, M.M. Hoeper
, V.V. McLaughlin
, A.J. Peacock
, G. Simonneau
, J.L. Vachiery
, E. Grunig
, R.J. Oudiz
, A. Vonk-Noordegraaf
, R.J. White
, C. Blair
, H. Gillies
, K.L. Miller
, J.H.N. Harris
, J. Langley
, L.J. Rubin

Research output: Contribution to journal › Article › Academic › peer-review

37 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	834-844
Journal	New England journal of medicine
Volume	373
Issue number	9
DOIs	https://doi.org/10.1056/NEJMoa1413687
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1056/NEJMoa1413687

Initial-use-of-ambrisentan-plus-tadalafil-in-pulmonary-arterial-hypertension.pdfFinal published version, 481 KBLicence: Taverne

Cite this

Galie, N., Barbera, J. A., Frost, A. E., Ghofrani, H. A., Hoeper, M. M., McLaughlin, V. V., Peacock, A. J., Simonneau, G., Vachiery, J. L., Grunig, E., Oudiz, R. J., Vonk-Noordegraaf, A., White, R. J., Blair, C., Gillies, H., Miller, K. L., Harris, J. H. N., Langley, J., & Rubin, L. J. (2015). Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. New England journal of medicine, 373(9), 834-844. https://doi.org/10.1056/NEJMoa1413687

@article{cb87010ade774494955ea531c9e97bea,

title = "Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension",

author = "N. Galie and J.A. Barbera and A.E. Frost and H.A. Ghofrani and M.M. Hoeper and V.V. McLaughlin and A.J. Peacock and G. Simonneau and J.L. Vachiery and E. Grunig and R.J. Oudiz and A. Vonk-Noordegraaf and R.J. White and C. Blair and H. Gillies and K.L. Miller and J.H.N. Harris and J. Langley and L.J. Rubin",

year = "2015",

doi = "10.1056/NEJMoa1413687",

language = "Undefined/Unknown",

volume = "373",

pages = "834--844",

journal = "New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "9",

}

Galie, N, Barbera, JA, Frost, AE, Ghofrani, HA, Hoeper, MM, McLaughlin, VV, Peacock, AJ, Simonneau, G, Vachiery, JL, Grunig, E, Oudiz, RJ, Vonk-Noordegraaf, A, White, RJ, Blair, C, Gillies, H, Miller, KL, Harris, JHN, Langley, J & Rubin, LJ 2015, 'Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension', New England journal of medicine, vol. 373, no. 9, pp. 834-844. https://doi.org/10.1056/NEJMoa1413687

TY - JOUR

T1 - Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

AU - Galie, N.

AU - Barbera, J.A.

AU - Frost, A.E.

AU - Ghofrani, H.A.

AU - Hoeper, M.M.

AU - McLaughlin, V.V.

AU - Peacock, A.J.

AU - Simonneau, G.

AU - Vachiery, J.L.

AU - Grunig, E.

AU - Oudiz, R.J.

AU - Vonk-Noordegraaf, A.

AU - White, R.J.

AU - Blair, C.

AU - Gillies, H.

AU - Miller, K.L.

AU - Harris, J.H.N.

AU - Langley, J.

AU - Rubin, L.J.

PY - 2015

Y1 - 2015

U2 - 10.1056/NEJMoa1413687

DO - 10.1056/NEJMoa1413687

M3 - Article

C2 - 26308684

SN - 0028-4793

VL - 373

SP - 834

EP - 844

JO - New England journal of medicine

JF - New England journal of medicine

IS - 9

ER -